IDYA vs. IR
Compare and contrast key facts about IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IDYA or IR.
Key characteristics
IDYA | IR | |
---|---|---|
YTD Return | -2.33% | 21.29% |
1Y Return | 18.68% | 41.67% |
3Y Return (Ann) | 8.99% | 20.18% |
5Y Return (Ann) | 31.08% | 27.64% |
Sharpe Ratio | 0.44 | 1.61 |
Daily Std Dev | 46.10% | 25.73% |
Max Drawdown | -74.64% | -49.12% |
Current Drawdown | -26.27% | -6.61% |
Fundamentals
IDYA | IR | |
---|---|---|
Market Cap | $2.94B | $37.82B |
EPS | -$2.18 | $2.02 |
Total Revenue (TTM) | $11.96M | $7.04B |
Gross Profit (TTM) | $7.77M | $2.88B |
EBITDA (TTM) | -$189.27M | $1.54B |
Correlation
The correlation between IDYA and IR is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
IDYA vs. IR - Performance Comparison
In the year-to-date period, IDYA achieves a -2.33% return, which is significantly lower than IR's 21.29% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IDYA vs. IR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IDYA vs. IR - Dividend Comparison
IDYA has not paid dividends to shareholders, while IR's dividend yield for the trailing twelve months is around 0.09%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
IDEAYA Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Ingersoll-Rand Plc | 0.09% | 0.10% | 0.15% | 0.03% | 2.33% | 5.78% | 9.58% | 3.83% |
Drawdowns
IDYA vs. IR - Drawdown Comparison
The maximum IDYA drawdown since its inception was -74.64%, which is greater than IR's maximum drawdown of -49.12%. Use the drawdown chart below to compare losses from any high point for IDYA and IR. For additional features, visit the drawdowns tool.
Volatility
IDYA vs. IR - Volatility Comparison
IDEAYA Biosciences, Inc. (IDYA) has a higher volatility of 9.67% compared to Ingersoll-Rand Plc (IR) at 6.58%. This indicates that IDYA's price experiences larger fluctuations and is considered to be riskier than IR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
IDYA vs. IR - Financials Comparison
This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Ingersoll-Rand Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities